Aequus Pharmaceuticals Inc. (AQSZF)

Aequus Pharmaceuticals Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.05	0.17	0.25	2.39	1.72
Short-Term Investments	-	-	-	0.04	-
Cash & Short-Term Investments	0.05	0.17	0.25	2.44	1.72
Cash Growth	-70.48%	-31.87%	-89.75%	41.75%	254.77%
Accounts Receivable	0.06	0.03	0.31	0.94	0.78
Receivables	0.06	0.03	0.31	0.94	0.78
Inventory	0.04	0.12	0.09	0.14	0.12
Prepaid Expenses	0.14	0.07	0.2	0.08	0.15
Other Current Assets	-	0.04	0.04	-	-
Total Current Assets	0.28	0.44	0.9	3.59	2.77
Property, Plant & Equipment	0.52	0.65	0.79	0.24	0.37
Total Assets	0.8	1.09	1.69	4.35	3.13
Accounts Payable	0.54	0.27	0.09	0.16	0.16
Accrued Expenses	0.1	0.04	0.2	0.22	0.08
Short-Term Debt	6.03	4.37	2	-	-
Current Portion of Long-Term Debt	-	-	-	1.93	-
Current Portion of Leases	0.12	0.11	0.09	0.15	0.15
Total Current Liabilities	6.8	4.8	2.38	2.46	0.38
Long-Term Debt	-	-	-	0.03	1.98
Long-Term Leases	0.46	0.58	0.69	0.08	0.2
Total Liabilities	7.26	5.38	3.07	2.56	2.56
Common Stock	23.99	23.99	23.99	23.99	21.17
Retained Earnings	-34.86	-32.68	-29.72	-26.51	-24.7
Comprehensive Income & Other	4.42	4.4	4.35	4.31	4.1
Shareholders' Equity	-6.45	-4.29	-1.38	1.79	0.57
Total Liabilities & Equity	0.8	1.09	1.69	4.35	3.13
Total Debt	6.61	5.06	2.78	2.18	2.32
Net Cash (Debt)	-6.56	-4.89	-2.53	0.26	-0.6
Net Cash Per Share	-0.05	-0.04	-0.02	0.00	-0.01
Filing Date Shares Outstanding	132.63	132.63	132.63	132.63	132.63
Total Common Shares Outstanding	132.63	132.63	132.63	132.63	111.92
Working Capital	-6.51	-4.36	-1.48	1.14	2.38
Book Value Per Share	-0.05	-0.03	-0.01	0.01	0.01
Tangible Book Value	-6.45	-4.29	-1.38	1.79	0.57
Tangible Book Value Per Share	-0.05	-0.03	-0.01	0.01	0.01
Machinery	-	0.04	0.04	0.04	0.04
Leasehold Improvements	-	0	0	0	0

Source: S&P Global Market Intelligence. Standard template. Financial Sources.